 |
L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-L-ser |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of delayed graft function following renal transplant |
| USA Market Approval | USA |
| USA Designation Date | 2009-09-18 00:00:00 |
| Sponsor | Araim Pharmaceuticals, Inc.;712 Kitchawan Road;Ossining, New York, 10562 |
